Company / Operating Cash Flow per Share
Barinthus Biotherapeutics plc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.19
FY2025
5-year range
-$1.39 / -$0.38
FY2021-FY2025
Trend
+9.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.38 to $-1.19 over the past 2 years.
Based on SEC 10-K filings.
-1.19 in FY2025.
Declined from $-0.38 to $-1.19 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 9.5% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.19 | +9.5% |
| FY2024 | -$1.32 | -244.1% |
| FY2023 | -$0.38 | +56.3% |
| FY2022 | -$0.88 | +36.8% |
| FY2021 | -$1.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026